Cardinal Health, Inc. (NYSE:CAH – Free Report) – Zacks Research boosted their FY2024 earnings per share (EPS) estimates for Cardinal Health in a note issued to investors on Wednesday, April 17th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $7.22 per share for the year, up from their prior forecast of $7.21. The consensus estimate for Cardinal Health’s current full-year earnings is $7.28 per share. Zacks Research also issued estimates for Cardinal Health’s Q4 2024 earnings at $1.74 EPS, Q1 2025 earnings at $1.81 EPS, Q4 2025 earnings at $2.08 EPS, FY2025 earnings at $7.95 EPS and FY2026 earnings at $8.18 EPS.
Cardinal Health (NYSE:CAH – Get Free Report) last released its earnings results on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. The firm had revenue of $57.45 billion for the quarter, compared to analysts’ expectations of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.32 earnings per share.
Check Out Our Latest Stock Report on CAH
Cardinal Health Trading Down 0.5 %
NYSE:CAH opened at $106.00 on Thursday. The stock has a market cap of $25.78 billion, a P/E ratio of 41.73, a price-to-earnings-growth ratio of 1.03 and a beta of 0.68. The stock’s 50-day moving average is $109.53 and its 200-day moving average is $104.03. Cardinal Health has a 1-year low of $77.56 and a 1-year high of $116.04.
Hedge Funds Weigh In On Cardinal Health
Institutional investors and hedge funds have recently bought and sold shares of the stock. Clearstead Trust LLC bought a new stake in shares of Cardinal Health in the 4th quarter worth approximately $25,000. Raleigh Capital Management Inc. lifted its stake in shares of Cardinal Health by 4,466.7% in the 4th quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock valued at $28,000 after purchasing an additional 268 shares during the period. Cornerstone Planning Group LLC purchased a new position in shares of Cardinal Health in the 3rd quarter valued at approximately $26,000. BKM Wealth Management LLC purchased a new position in shares of Cardinal Health in the 4th quarter valued at approximately $30,000. Finally, Clear Street Markets LLC purchased a new position in shares of Cardinal Health in the 4th quarter valued at approximately $30,000. 87.17% of the stock is currently owned by institutional investors.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 annualized dividend and a yield of 1.89%. Cardinal Health’s payout ratio is 78.74%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- The Significance of Brokerage Rankings in Stock Selection
- Comprehensive PepsiCo Stock Analysis
- Where to Find Earnings Call Transcripts
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Invest in Insurance Companies: A GuideĀ
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.